120 related articles for article (PubMed ID: 22972598)
21. Role of HIV-1 Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection.
Li JC; Yim HC; Lau AS
AIDS; 2010 Jul; 24(11):1609-23. PubMed ID: 20588103
[No Abstract] [Full Text] [Related]
22. HIV type 1 Gag as a target for antiviral therapy.
Waheed AA; Freed EO
AIDS Res Hum Retroviruses; 2012 Jan; 28(1):54-75. PubMed ID: 21848364
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death.
Nosheny RL; Bachis A; Acquas E; Mocchetti I
Eur J Neurosci; 2004 Dec; 20(11):2857-64. PubMed ID: 15579139
[TBL] [Abstract][Full Text] [Related]
24. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
[TBL] [Abstract][Full Text] [Related]
25. Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy.
Flores A; Quesada E
Curr Med Chem; 2013 Feb; 20(6):751-71. PubMed ID: 23278399
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV-1 entry: multiple keys to close the door.
Hertje M; Zhou M; Dietrich U
ChemMedChem; 2010 Nov; 5(11):1825-35. PubMed ID: 20845361
[No Abstract] [Full Text] [Related]
27. Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.
Balachandran A; Wong R; Stoilov P; Pan S; Blencowe B; Cheung P; Harrigan PR; Cochrane A
Retrovirology; 2017 Jan; 14(1):7. PubMed ID: 28122580
[TBL] [Abstract][Full Text] [Related]
28. Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins.
Bachis A; Mocchetti I
Ann N Y Acad Sci; 2005 Aug; 1053():247-57. PubMed ID: 16179530
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial alterations in aging rat brain: effective role of (-)-epigallo catechin gallate.
Srividhya R; Zarkovic K; Stroser M; Waeg G; Zarkovic N; Kalaiselvi P
Int J Dev Neurosci; 2009 May; 27(3):223-31. PubMed ID: 19429387
[TBL] [Abstract][Full Text] [Related]
30. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
Jin H; Li D; Lin MH; Li L; Harrich D
Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
[TBL] [Abstract][Full Text] [Related]
31. The Discovery and Development of Oxalamide and Pyrrole Small Molecule Inhibitors of gp120 and HIV Entry - A Review.
Motati DR; Uredi D; Watkins EB
Curr Top Med Chem; 2019; 19(18):1650-1675. PubMed ID: 31424369
[TBL] [Abstract][Full Text] [Related]
32. Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus-gp120-mediated apoptosis.
Bachis A; Mocchetti I
J Neurosci Res; 2006 Apr; 83(5):890-6. PubMed ID: 16477610
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons.
Bachis A; Avdoshina V; Zecca L; Parsadanian M; Mocchetti I
J Neurosci; 2012 Jul; 32(28):9477-84. PubMed ID: 22787033
[TBL] [Abstract][Full Text] [Related]
34. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.
Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A
Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.
Dibbern DA; Glazner GW; Gozes I; Brenneman DE; Hill JM
J Clin Invest; 1997 Jun; 99(12):2837-41. PubMed ID: 9185505
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 inactivation by nucleic acid aptamers.
Held DM; Kissel JD; Patterson JT; Nickens DG; Burke DH
Front Biosci; 2006 Jan; 11():89-112. PubMed ID: 16146716
[TBL] [Abstract][Full Text] [Related]
37. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.
Liu S; Lu H; Zhao Q; He Y; Niu J; Debnath AK; Wu S; Jiang S
Biochim Biophys Acta; 2005 May; 1723(1-3):270-81. PubMed ID: 15823507
[TBL] [Abstract][Full Text] [Related]
38. Effects of HIV-1 gp120 and TAT-derived microvesicles on endothelial cell function.
Hijmans JG; Stockelman K; Levy M; Brewster LM; Bammert TD; Greiner JJ; Connick E; DeSouza CA
J Appl Physiol (1985); 2019 May; 126(5):1242-1249. PubMed ID: 30789287
[TBL] [Abstract][Full Text] [Related]
39. Scaffold hopping by "fuzzy" pharmacophores and its application to RNA targets.
Tanrikulu Y; Nietert M; Scheffer U; Proschak E; Grabowski K; Schneider P; Weidlich M; Karas M; Göbel M; Schneider G
Chembiochem; 2007 Nov; 8(16):1932-6. PubMed ID: 17896338
[No Abstract] [Full Text] [Related]
40. HIV-Tat regulates macrophage gene expression in the context of neuroAIDS.
Carvallo L; Lopez L; Fajardo JE; Jaureguiberry-Bravo M; Fiser A; Berman JW
PLoS One; 2017; 12(6):e0179882. PubMed ID: 28640909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
